← Back to home

BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER SUPERFICIAL (NON-INVASIVE)

Clinical trials for BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER SUPERFICIAL (NON-INVASIVE) explained in plain language.

Never miss a new study

Get alerted when new BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER SUPERFICIAL (NON-INVASIVE) trials appear

Sign up with your email to follow new studies for BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER SUPERFICIAL (NON-INVASIVE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1 Not yet finished but already full! 2

New bladder wash treatment aims to spare patients from major surgery

Disease control Not yet recruiting

This study is testing a new bladder wash treatment called NDV-01 for people with early-stage bladder cancer that hasn't spread into the muscle wall. The goal is to see if this treatment can better control the cancer and prevent it from coming back, potentially helping patients av…

Matched conditions: BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER SUPERFICIAL (NON-INVASIVE)

Phase: PHASE3 • Sponsor: Relmada Therapeutics, Inc. • Aim: Disease control

Last updated Apr 04, 2026 02:21 UTC

BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER SUPERFICIAL (NON-INVASIVE)

Get alerted when new BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER SUPERFICIAL (NON-INVASIVE) trials appear

New bladder wash treatment aims to spare patients from major surgery